![](/img/cover-not-exists.png)
Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancer
Slomovitz, Brian M, Chelariu-Raicu, Anca, Schmeler, Kathleen M, Lu, Karen H, Gershenson, David M, Wolf, Judith, Coleman, Robert LVolume:
30
Journal:
International Journal of Gynecologic Cancer
DOI:
10.1136/ijgc-2020-001859
Date:
November, 2020
File:
PDF, 1.23 MB
2020